Authorization

/DISREGARD RELEASE: Sino Medical Sciences Technology Inc. (SINOMED)/

We are advised by Sino Medical Sciences Technology Inc. (SINOMED) that journalists and other readers should disregard the news release, SINOMEDA® Completes Last Patient Follow-Up of the PIONEER-III Pivotal US and Japanese Trial of the BuMA SupremeA® Coronary Drug-Eluting Stent, issued 06-Jul-2020 over PR Newswire. This release was inadvertently issued early.SOURCE Sino Medical Sciences Technology Inc. (SINOMED)
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2022    »
ПнВтСрЧтПтСбВс
1234567
891011121314
15161718192021
22232425262728
293031